Founded with a mission to harness the power of science for a better world, Demetrix is a biotechnology company focused on researching and producing bioactive ingredients. The company specializes in creating nature-identical cannabinoids found in the Cannabis sativa plant, but without THC or plant material. Their core product offerings include various bioactive compounds aimed at enhancing health and wellness, with a strong emphasis on scientific efficacy and safety.
Demetrix has attracted notable investors and industry experts, contributing to its rapid growth and innovation in the biotech sector. The company's key achievements include the development of Arete-G™, a groundbreaking cannabinoid product, and significant advancements in cannabinoid research. By leveraging cutting-edge science, Demetrix has made a substantial impact on the biotechnology landscape, offering sustainable and effective alternatives to traditional plant-derived ingredients.
